NCT03021122

Brief Summary

The investigators recruit nurses working in 5 swiss Pediatric Emergency Departments or divisions to prepare continuous infusions of vasoactive drugs during a simulation-based pediatric CPR cardiac arrest scenario. According to randomization, nurses will have to prepare and deliver vasoactive drugs following their current conventional methods or by the aim of a mobile tablet application called PedAMINES™. PedAMINES™ is designed to support them step-by-step from order to delivery of these drugs.

  1. 1.Primary outcome will be to measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection.
  2. 2.Secondary outcome will be to measure the time to drug preparation (TDP) and time to drug delivery (TDD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

January 30, 2018

Status Verified

January 1, 2018

Enrollment Period

10 months

First QC Date

January 12, 2017

Last Update Submit

January 29, 2018

Conditions

Keywords

Medication errorsResuscitationDrugsPediatricsBiomedical technology

Outcome Measures

Primary Outcomes (1)

  • Medication dosage errors

    To measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection.

    On the day of study participation

Secondary Outcomes (1)

  • Time to drug preparation (TDP) and time to drug delivery (TDD)

    On the day of study participation

Study Arms (2)

Arm A (PedAMINES™ / Conventional Method)

EXPERIMENTAL

A 2-period study where nurses will be randomized to a 15-minute CPR scenario to prepare and deliver Dopamine with the help of PedAMINES™ first, then crossover (incl. washout period) to prepare and deliver Norepinephrine with the help of a Conventional Method.

Device: PedAMINES™ / Conventional Method

Arm B (Conventional Method / PedAMINES™)

ACTIVE COMPARATOR

A 2-period study where nurses will be randomized to a 15-minute CPR scenario to prepare and deliver Dopamine with the help of a Conventional Method first, then crossover (incl. washout period) to prepare and deliver Norepinephrine with the help of PedAMINES™.

Device: Conventional Method / PedAMINES™

Interventions

Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • PedAMINES™ (Period 1) and then Conventional Method (Period 2)

Arm A (PedAMINES™ / Conventional Method)

Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • Conventional Method (Period 1) and then PedAMINES™ (Period 2)

Arm B (Conventional Method / PedAMINES™)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be nurse certified
  • To know how to prepare intravenous drugs injection.
  • To have previously completed the 5-minute introductory course to the use of PedAMINES dispensed by the investigators of the study.
  • Participation agreement

You may not qualify if:

  • To have at any time undergone a previous experiment with a cognitive numeric device aimed to help vasoactive drugs preparation.
  • To have not undergone the 5-minute introductory course to the use of PedAMINES.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Hôpital de l'Enfance (HEL)

Lausanne, Canton of Vaud, 1000, Switzerland

Location

Hôpital du Valais

Sion, Valais, 1950, Switzerland

Location

Inselspital Bern

Bern, 3010, Switzerland

Location

HFR Fribourg

Fribourg, 1752, Switzerland

Location

Geneva Children's Hospital, Geneva University Hospitals

Geneva, 1205, Switzerland

Location

Hôpital Neuchâtelois

Neuchâtel, 2000, Switzerland

Location

Related Publications (5)

  • Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, Carroll CL, Berens RJ, Praestgaard A, Weissfeld L, Spinella PC; American Heart Association's Get With The Guidelines-Resuscitation (Formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation. 2013 Jan 29;127(4):442-51. doi: 10.1161/CIRCULATIONAHA.112.125625. Epub 2013 Jan 22.

    PMID: 23339874BACKGROUND
  • Siebert JN, Ehrler F, Combescure C, Lacroix L, Haddad K, Sanchez O, Gervaix A, Lovis C, Manzano S. A Mobile Device App to Reduce Time to Drug Delivery and Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial. J Med Internet Res. 2017 Feb 1;19(2):e31. doi: 10.2196/jmir.7005.

    PMID: 28148473BACKGROUND
  • Siebert JN, Gosetto L, Sauvage M, Bloudeau L, Suppan L, Rodieux F, Haddad K, Hugon F, Gervaix A, Lovis C, Combescure C, Manzano S, Ehrler F; PedAMINES Trial Group; PedAMINES Prehospital Group. Usability Testing and Technology Acceptance of an mHealth App at the Point of Care During Simulated Pediatric In- and Out-of-Hospital Cardiopulmonary Resuscitations: Study Nested Within 2 Multicenter Randomized Controlled Trials. JMIR Hum Factors. 2022 Mar 1;9(1):e35399. doi: 10.2196/35399.

  • Siebert JN, Ehrler F, Combescure C, Lovis C, Haddad K, Hugon F, Luterbacher F, Lacroix L, Gervaix A, Manzano S; PedAMINES Trial Group. A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial. Lancet Child Adolesc Health. 2019 May;3(5):303-311. doi: 10.1016/S2352-4642(19)30003-3. Epub 2019 Feb 21.

  • Siebert JN, Ehrler F, Lovis C, Combescure C, Haddad K, Gervaix A, Manzano S. A Mobile Device App to Reduce Medication Errors and Time to Drug Delivery During Pediatric Cardiopulmonary Resuscitation: Study Protocol of a Multicenter Randomized Controlled Crossover Trial. JMIR Res Protoc. 2017 Aug 22;6(8):e167. doi: 10.2196/resprot.7901.

Study Officials

  • Johan N Siebert, MD

    Geneva Children Hospital, Geneva University Hospitals, Geneva, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Blinding to the purpose of the study during recruitment will be maintained to minimize preparation bias. Nurses will be "unblinded" when the simulated scenario start.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD: Emergency Physician

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 13, 2017

Study Start

March 1, 2017

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

January 30, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will share

IPD will be deidentified and the study investigators will house the data locally on secure hard disk drives (HDD) at the Geneva Children's Hospital. Data will be freely available to anyone upon request 1 year after study completion. Only deidentified/anonymized data will be shared.

Locations